These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial. Woolery-Lloyd H; Baumann L; Ikeno H J Cosmet Dermatol; 2010 Mar; 9(1):22-7. PubMed ID: 20367669 [TBL] [Abstract][Full Text] [Related]
28. Rapid and efficacious fixed-combination monotherapy: desired results for the patient and improved adherence for the clinician. Kircik L Cutis; 2009 Nov; 84(5 Suppl):5-11. PubMed ID: 19999187 [TBL] [Abstract][Full Text] [Related]
30. Topical tetraynoic acid. Haroon TS; Hall J; Lyell A; Alexandra JO Br J Dermatol; 1970 Sep; 83(3):418-9. PubMed ID: 4249183 [No Abstract] [Full Text] [Related]
31. Rethinking treatment of acne in the severe patient. Thiboutot D J Drugs Dermatol; 2011 Jun; 10(6):s8-12. PubMed ID: 21780340 [TBL] [Abstract][Full Text] [Related]
32. A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris. Yentzer BA; Gosnell AL; Clark AR; Pearce DJ; Balkrishnan R; Camacho FT; Young TA; Fountain JM; Fleischer AB; Colón LE; Johnson LA; Preston N; Feldman SR J Am Acad Dermatol; 2011 Apr; 64(4):793-5. PubMed ID: 21414505 [No Abstract] [Full Text] [Related]
33. [New treatment strategy in acne vulgaris. Antibiotic prescription must be limited]. Mobacken H; Oprica C; Berg M Lakartidningen; 2012 May 30-Jun 4; 109(22):1085-9. PubMed ID: 22808657 [No Abstract] [Full Text] [Related]
34. A qualitative and quantitative assessment of the application and use of topical acne medication by patients. Del Rosso JQ Cutis; 2005 Aug; 76(2):109-13. PubMed ID: 16209156 [No Abstract] [Full Text] [Related]
35. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne. Kaymak Y; Ilter N J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042 [TBL] [Abstract][Full Text] [Related]
36. Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne. Stinco G; Bragadin G; Trotter D; Pillon B; Patrone P J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):320-5. PubMed ID: 17309452 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris. Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221 [TBL] [Abstract][Full Text] [Related]
38. Topical acne treatment with acetylcysteine: clinical and experimental effects. Montes LF; Wilborn WH; Montes CM Skinmed; 2012; 10(6):348-51. PubMed ID: 23346662 [TBL] [Abstract][Full Text] [Related]
39. Creation of a tool to assess adherence to treatments for acne. Pawin H; Beylot C; Chivot M; Faure M; Poli F; Revuz J; Dréno B Dermatology; 2009; 218(1):26-32. PubMed ID: 18946201 [TBL] [Abstract][Full Text] [Related]